Influx rate of 18 F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts

European Journal of Nuclear Medicine and Molecular Imaging(2019)

引用 11|浏览7
暂无评分
摘要
Purpose 18 F-fluoroaminosuberic acid ( 18 F-FASu) is a recently developed amino acid tracer for positron emission tomography (PET) of oxidative stress that may offer improved tumour assessment over the conventional tracer 18 F-fluorodeoxyglucose ( 18 F-FDG). Our aim was to evaluate and relate dynamic 18 F-FASu and 18 F-FDG uptake with pharmacokinetic modelling to transporter protein expression levels in a panel of diverse tumour xenograft lines. Methods Four different tumour xenograft lines were implanted in female athymic nude mice: MAS98.12 and HBCx3 (breast), TPMX (osteosarcoma) and A549 (lung). Dynamic PET over 60 min was performed on a small animal unit. The time–activity curves (TACs) for 18 F-FASu and 18 F-FDG in individual tumours were used to extract early (SUV E ; 2 min p.i.) and late (SUV L ; 55 min p.i.) standardised uptake values. Pharmacokinetic two-tissue compartment models were applied to the TACs to estimate rate constants K 1 –k 4 and blood volume fraction v B . Relative levels of cystine/glutamate antiporter subunit xCT were assessed by western blotting, and expression of GLUT1 and CD31 by immunohistochemistry. Results 18 F-FASu showed higher SUV E , whilst 18 F-FDG exhibited higher SUV L . Influx rate K 1 for 18 F-FASu was significantly correlated with xCT levels ( p = 0.001) and was significantly higher than K 1 for 18 F-FDG ( p < 0.001). K 1 for 18 F-FDG was significantly correlated with GLUT1 levels ( p = 0.002). v B estimated from 18 F-FASu and 18 F-FDG TACs was highly consistent and significantly correlated ( r = 0.85, p < 0.001). Two qualitatively different 18 F-FASu uptake profiles were identified: type α with low xCT expression and low K 1 (A549 and HBCx3), and type β with high xCT expression and high K 1 (MAS98.12 and TPMX). Conclusion The influx rate of 18 F-FASu reflects xCT activity in tumour xenografts. Dynamic PET with pharmacokinetic modelling is needed to fully appraise 18 F-FASu distribution routes.
更多
查看译文
关键词
Cancer,Xenograft,Mouse model,System XC−,xCT,18F-fluoroaminosuberic acid,18F-FDG,Dynamic PET,Pharmacokinetic modelling,Oxidative stress
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要